MENTOMED PLUS Tablets and Suspension – Montelukast + Levocetirizine
Composition: MENTOMED PLUS contains Montelukast and Levocetirizine. The strength and exact composition of each tablet and suspension should be confirmed from the approved product label.
Product Family: MENTOMED PLUS belongs to the antiallergic and respiratory medicine category, combining a leukotriene receptor antagonist with a second-generation antihistamine.
Product Overview: MENTOMED PLUS combines montelukast and levocetirizine to help manage selected allergic conditions. Montelukast blocks leukotrienes involved in inflammation and airway narrowing, while levocetirizine helps reduce the effects of histamine responsible for common allergy symptoms.
Indications: Depending on the approved product labeling, this combination may be prescribed for allergic rhinitis and associated symptoms such as sneezing, runny nose, nasal itching, and itchy or watery eyes. Montelukast may also be prescribed for selected asthma-related indications, but this combination is not intended to treat an acute asthma attack.
Clinical Benefits: MENTOMED PLUS provides complementary antiallergic actions to help relieve nasal and other allergy symptoms. The combination may support improved symptom control when both ingredients are clinically appropriate for the patient.
Dosage and Administration: The dosage depends on the patient's age, the strength and formulation, and the prescribing healthcare professional's assessment. Tablets and suspension are not automatically interchangeable on a volume-for-tablet basis. Follow the approved product label and do not exceed the recommended dose.
Directions for Use: Use MENTOMED PLUS exactly as directed by a healthcare professional. Shake the suspension well before use and measure each dose with a suitable measuring device. Patients should inform their healthcare professional about other medicines they are taking.
Precautions: Montelukast carries a warning regarding serious neuropsychiatric events, including changes in mood or behavior and suicidal thoughts or actions. Patients and caregivers should seek medical advice promptly if these symptoms occur. For allergic rhinitis, montelukast is generally reserved for patients who do not respond adequately to or cannot tolerate alternative treatments. Levocetirizine may cause drowsiness in some patients.
Product Highlights: MENTOMED PLUS combines two complementary antiallergic ingredients in tablet and suspension formulations, offering options for patients who require treatment for selected allergy symptoms.
Product Summary: MENTOMED PLUS contains montelukast and levocetirizine to support the management of selected allergic conditions when prescribed appropriately. The exact strengths, age recommendations, and approved indications should be verified against the registered product information.
Medical Notice: This product description is intended for informational and professional website use. Confirm the exact ingredient strengths, suspension concentration, approved age groups, and local prescribing information before publication.
Company: INTERMED